Residex Ventures B.V. Company Profile

15:35 EDT 18th March 2018 | BioPortfolio

Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North American companies. Residex Ventures is currently setting up their third fund and has two funds under management.


Kosterijland 70-78
3981 AJ


Phone: 31 (0) 30-659 55 00
Fax: 31 (0) 30-659 55 11

News Articles [256 Associated News Articles listed on BioPortfolio]

Eko raises $5mm in Series A round

Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and

Eko raises $5M Series A to add staff, support clinical studies for digital stethoscope

ARTIS Ventures led the Series A round. Other investors that took part included Strategic Partners, Dreamlt Ventures, 1812 Ventures, and

Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic

The round was led by New Enterprise Associates and joined by Sofinnova Ventures and Vida Ventures, as well as existing investors OrbiMed, SV Health Investors, Osage University Partners, and Mission Ba...

New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

Abbvie, Pfizer Jump in on Newly-Launched Jnana Therapeutics' $50M Funding Round

Seed funders Polaris Partners and Avalon Ventures were joined in the Series A syndicate by Versant Ventures, AbbVie Ventures, and Pfizer R&D Innovate.

HealthiPASS Raises $7.2M for Patient-Centric Digital Payments Platform

HealthiPASS,  a Chicago-based healthcare payments company, today announced it has raised a $7.2 million in Series A funding round, led by FCA Venture Partners. The round also included participation ...

Microsoft Ventures announces Innovate.AI, a global search for startups shaping the future of AI

Presented in partnership with Madrona Venture Group, Notion Capital and Vertex Ventures Israel. SAN FRANCISCO, Oct. 10, 2017 /PRNewswire/ -- Microsoft Ventures, in collaboration with Madrona Ventu...

Quentis Therapeutics raises $48mm through Series A round

Cancer immunotherapy developer Quentis Therapeutics Inc. raised $48mm through its Series A round from co-lead investors Versant Ventures, Polaris Ventures, and LS Polaris Innovation Fund, along with a...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Femicide: a Avoidable Mortality? The "Tivoli" Model.

The Instabul Convention is a normative tool for the prevention of women's violence in Europe. Rome 5 Local Healthcare Authority has implemented a synergistic intervention model in joint ventures with ...

Tiny Conveyance: Micro- and Nanorobots Prepare to Advance Medicine.

In the science-fiction classic Fantastic Voyage [1], a shrink-ray zaps a submarine and the crew within it, and the resulting microscopic vehicle ventures inside a human body to destroy a blood clot an...

Evaluating Resident Perspectives on International Humanitarian Missions.

Opportunities for international missions are highly sought after by medical students, residents, and attending plastic surgeons. The educational benefits and ethical considerations of trainees partici...

With tree nut sensitization, take the current when it serves, or lose our ventures.

Tree nut allergy affects approximately 1.4-2.3%, depending on the study methodology, patient age, and region in which the study was conducted.1,2 Tree nut allergy can be severe, and tends to persist t...

Exploring local people's views on the livelihood impacts of privately versus community managed conservation strategies in the Ruvuma landscape of North Mozambique-South Tanzania.

It is broadly acknowledged that natural resources conservation strategies affect the livelihoods of local communities. Moreover, evidence suggests that these livelihood impacts, in turn, can influence...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [527 Associated Companies listed on BioPortfolio]

Residex Ventures B.V.

Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

Jina Ventures

Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...

Rizk Ventures

Rizk Ventures is a privately-held investment firm based in New York, founded by Thomas A. Rizk and Linda Rizk. Rizk Ventures focuses on investment activities in the areas of Ventu...

More Information about "Residex Ventures B.V." on BioPortfolio

We have published hundreds of Residex Ventures B.V. news stories on BioPortfolio along with dozens of Residex Ventures B.V. Clinical Trials and PubMed Articles about Residex Ventures B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Residex Ventures B.V. Companies in our database. You can also find out about relevant Residex Ventures B.V. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record